UB Paderborn / Katalog / Suche / in CDI

Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-07, Vol.48 (7), p.721-729

2009

Link zum Volltext

Verfügbarkeit prüfen

Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Dermatology and therapy, 2024-01, Vol.14 (1), p.261-270

2024

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Dermatology and therapy, 2024-05, Vol.14 (5), p.1367-1369

2024

Link zum Volltext

Verfügbarkeit prüfen

Type 2 cytokines sensitize human sensory neurons to itch-associated stimuli

Frontiers in molecular neuroscience, 2023-10, Vol.16, p.1258823-1258823

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency

Journal of Virology, 2002-08, Vol.76 (16), p.8118-8123

2002

Link zum Volltext

Verfügbarkeit prüfen

541 - Real-world effectiveness of dupilumab in adult and adolescent patients with atopic dermatitis: 3-year data from the PROSE registry

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii40-ii41

2024

Link zum Volltext

Verfügbarkeit prüfen

41658 Real-World Eﬀectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 2-Year Data From the PROSE Registry

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB81-AB81

2023

Link zum Volltext

Verfügbarkeit prüfen

386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Link zum Volltext

Verfügbarkeit prüfen

566 - Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii60-ii60

2024

Link zum Volltext

Verfügbarkeit prüfen

561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

British journal of dermatology (1951), 2024-02, Vol.190 (Supplement_2), p.ii55-ii56

2024

Link zum Volltext

Verfügbarkeit prüfen

More money, fewer lives: the cost effectiveness of welfare reform in the United States

American journal of public health (1971), 2015-02, Vol.105 (2), p.324-328

2015

Link zum Volltext

Verfügbarkeit prüfen

27434 Early trends of disease improvement in adult patients with atopic dermatitis treated with dupilumab: Real-world data from the PROSE registry

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB32-AB32

2021

Link zum Volltext

Verfügbarkeit prüfen

Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes

Journal of drugs in dermatology, 2016-10, Vol.15 (10), p.1260

2016

Link zum Volltext

Verfügbarkeit prüfen

Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris

The Journal of clinical and aesthetic dermatology, 2015-12, Vol.8 (12), p.22-26

2015

Link zum Volltext

Verfügbarkeit prüfen

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris

Journal of drugs in dermatology, 2014-09, Vol.13 (9), p.1083

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10

Journal of drugs in dermatology, 2015-08, Vol.14 (8), p.871

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder

Depression and anxiety, 2008-10, Vol.25 (10), p.854-861

2008

Link zum Volltext

Verfügbarkeit prüfen

The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis

Dermatology and therapy, 2021-10, Vol.11 (5), p.1707-1715

2021

Link zum Volltext

Verfügbarkeit prüfen

Penetration of (14C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish

The Journal of clinical and aesthetic dermatology, 2014-09, Vol.7 (9), p.34-36

2014

Link zum Volltext

Verfügbarkeit prüfen

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

Depression and anxiety, 2004, Vol.19 (4), p.234-240

2004

Link zum Volltext

Verfügbarkeit prüfen

Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)

Skin (Milwood, N.Y.), 2020-10, Vol.4 (6), p.s106

2020

Link zum Volltext

Verfügbarkeit prüfen

Atopic Dermatitis (AD) Disease History With AD Treatment History in a Cohort of AD Patients Treated With Dupilumab From a Real-World Registry (PROSE)

Skin (Milwood, N.Y.), 2020-10, Vol.4 (6), p.s105

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)

Dermatology and therapy, 2022-06, Vol.12 (6), p.1417-1430

2022

Link zum Volltext

Verfügbarkeit prüfen

Topical Treatment for Onychomycosis: Is it More Effective than the Clinical Data Suggests?

The Journal of clinical and aesthetic dermatology, 2016-11, Vol.9 (11), p.34-39

2016

Link zum Volltext

Verfügbarkeit prüfen

Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris

The Journal of clinical and aesthetic dermatology, 2015-12, Vol.8 (12), p.22-26

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial

Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Type 2 cytokines sensitize human sensory neurons to itch-associated stimuli

Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency

541 - Real-world effectiveness of dupilumab in adult and adolescent patients with atopic dermatitis: 3-year data from the PROSE registry

41658 Real-World Eﬀectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 2-Year Data From the PROSE Registry

386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice

566 - Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial

561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

More money, fewer lives: the cost effectiveness of welfare reform in the United States

27434 Early trends of disease improvement in adult patients with atopic dermatitis treated with dupilumab: Real-world data from the PROSE registry

Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes

Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris

Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10

Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder

The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis

Penetration of (14C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)

Atopic Dermatitis (AD) Disease History With AD Treatment History in a Cohort of AD Patients Treated With Dupilumab From a Real-World Registry (PROSE)

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)

Topical Treatment for Onychomycosis: Is it More Effective than the Clinical Data Suggests?

Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris

Suchergebnisse filtern